GlobeNewswire

RAMSAY SANTE obtains approval from the Australian Securities Exchange for its foreign exempt listing in Australia
12/11/2026
REGULATORY INFORMATION Paris, November 12, 2026 Ramsay Santé obtains approval from the Australian Securities Exchange for its foreign exempt listing in Australia Ramsay Santé today announces that the Australian [...]
RAMSAY SANTE obtient l'approbation de l'Australian Securities Exchange pour sa cotation en Australie en tant qu'entité étrangère exemptée
12/11/2026
INFORMATION RÉGLEMENTÉE Paris le 12 novembre 2026 Ramsay Santé obtient l’approbation de l’ Australian Securities Exchange pour sa cotation en Australie en tant qu’entité étrangère exemptée Ramsay Santé annonce aujourd’ [...]
Mironid strengthens Board and clinical team to support next phase of growth
12/11/2026
Dr. Omar Khwaja joins the Board as Non-Executive Director Senior leadership team further strengthened with the appointments of Lars Erwig and Kimberly Hoffman Glasgow, Scotland, November 12, 2026 – Mironid, a [...]
Zealand Pharma Announces Financial Results for the First Nine Months of 2026
12/11/2026
Company announcement – No. 56 / 2026 Zealand Pharma Announces Financial Results for the First Nine Months of 2026 Advancing at pace towards Metabolic Frontier 2030: petrelintide in Phase 3, survodutide moving towards [...]
Santhera Signs Distribution Agreement with SteinCares for AGAMREE® (Vamorolone) in 31 countries across Latin America and the Caribbean
12/11/2026
Pratteln, Switzerland, November 12, 2026 – Santhera Pharmaceuticals (SIX: SANN) announces it has signed an exclusive agreement with SteinCares for the distribution of AGAMREE® (vamorolone) for the treatment of Duchenne [...]
Top Outsourcing Medical Billing Services at Remitwright: Denial Management, A/R Recovery, Credentialing, NEMT and Home Care Billing Launch the Company's 2027 Service Line
12/11/2026
The New York medical billing company details the outsourcing medical billing services it is built around, what each one delivers, and how a dedicated billing team changes the result for independent practices. New York [...]
Glass House Brands Announces Change of Auditor
12/11/2026
LONG BEACH, Calif. and TORONTO, Nov. 11, 2026 (GLOBE NEWSWIRE) -- Glass House Brands Inc. ("Glass House" or the "Company") (CBOE CA: GLAS.A.U) (NYSE: GLAS) today announced that BDO USA, P.C. ("BDO") resigned as auditor [...]
Juniper Biosciences Builds Clinical and Commercial Leadership Teams with Appointments of Deepak Behera, M.D., as Chief Medical Officer, Javed Mahmood, Ph.D., as Senior Director of Clinical Development, and Robert Sgroi as Chief Commercial Officer
11/11/2026
BEDMINSTER, N.J., Nov. 11, 2026 (GLOBE NEWSWIRE) -- Juniper Biosciences ("Juniper" or "the Company"), a radiopharmaceutical drug development company, today announced the establishment of its clinical team with the [...]
CORRECTION: Milestone Scientific Schedules Third Quarter 2026 Financial Results Conference Call
11/11/2026
In a release issued under the same headline earlier today by Milestone Scientific, Inc., please note that in the first paragraph of the release, the conference call date should have been Friday, November 13, not [...]
Addex Spin-out Neurosterix Closes $105 Million Series B Financing
11/11/2026
Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, November 11, 2026 - Addex Therapeutics (SIX and Nasdaq: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small [...]
Solana Company Reports Third Quarter 2026 Financial Results
11/11/2026
PHILADELPHIA, Nov. 11, 2026 (GLOBE NEWSWIRE) -- Solana Company (NASDAQ: HSDT) (the “Company” or “HSDT”), a publicly listed digital asset treasury, infrastructure, and services company providing institutional access to [...]
Alvotech Announces Financial Results for the Nine Months to September 30, 2026, with a Business Update
11/11/2026
REYKJAVIK, Iceland, Nov. 11, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO; ALVO-SDB) (“Alvotech” or the “Company”), a global biotechnology company specializing in the development and manufacture of biosimilar [...]
Alvotech Announces Financial Results for the Nine Months to September 30, 2026, with a Business Update
11/11/2026
REYKJAVIK, ICELAND (November 11, 2026) — Alvotech (NASDAQ: ALVO; ALVO-SDB) (“Alvotech” or the “Company”), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for [...]
Milestone Scientific Schedules Third Quarter 2026 Financial Results Conference Call
11/11/2026
ROSELAND, N.J., Nov. 11, 2026 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that [...]
InspireMD Announces Updated Timing for Third Quarter 2026 Financial Results
11/11/2026
MIAMI, Nov. 11, 2026 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard ® Prime carotid stent system for the prevention of stroke, today announced that it has rescheduled its third quarter 2026 [...]
Beyond Air Reports Financial Results and Provides Corporate Update for the Quarter Ended September 30, 2026
11/11/2026
Record quarterly revenue of $2.3 million, representing approximately 28% year-over-year growth, reflecting continued adoption of first-generation LungFit PH PMA supplement for second-generation LungFit PH system remains [...]
SpyGlass Pharma Reports Third Quarter 2026 Financial Results and Provides Corporate Updates
11/11/2026
Acquired Advanced Vision Science, Inc. (AVS), securing scalable commercial intraocular lens (IOL) manufacturing capacity for its Phase 3 lead product candidate the Bimatoprost Drug Pad-IOL System (BIM-IOL System) and [...]
SeaStar Medical Reports Third Quarter 2026 Financial Results and Provides Business Updates
11/11/2026
Continued adoption of the QUELIMMUNE ® therapy yielded 247% increase in net revenue compared to the third quarter of 2025 Achieved nearly 75% enrollment in the NEUTRALIZE-AKI pivotal clinical trial in adult patients [...]
Vivani Medical Reports Third Quarter 2026 Financial Results and Provides Business Update
11/11/2026
Top-line results for SLIM-1™, the first-in-human Phase 1 trial of NPM-139, Vivani's miniature, ultra-long-acting semaglutide implant under development for chronic weight management, are anticipated for announcement [...]

Pages

Other news

Test 2

Lorem ipsum

Test 1

Lorem upsum